220 related articles for article (PubMed ID: 24577532)
1. How we manage follicular lymphoma.
Hiddemann W; Cheson BD
Leukemia; 2014 Jul; 28(7):1388-95. PubMed ID: 24577532
[TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma: 2014 update on diagnosis and management.
Freedman A
Am J Hematol; 2014 Apr; 89(4):429-36. PubMed ID: 24687887
[TBL] [Abstract][Full Text] [Related]
3. Treatment of follicular lymphoma.
Izutsu K
J Clin Exp Hematop; 2014; 54(1):31-7. PubMed ID: 24942944
[TBL] [Abstract][Full Text] [Related]
4. Follicular lymphoma: evolving therapeutic strategies.
Kahl BS; Yang DT
Blood; 2016 Apr; 127(17):2055-63. PubMed ID: 26989204
[TBL] [Abstract][Full Text] [Related]
5. Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial.
Ardeshna KM; Qian W; Smith P; Braganca N; Lowry L; Patrick P; Warden J; Stevens L; Pocock CF; Miall F; Cunningham D; Davies J; Jack A; Stephens R; Walewski J; Ferhanoglu B; Bradstock K; Linch DC
Lancet Oncol; 2014 Apr; 15(4):424-35. PubMed ID: 24602760
[TBL] [Abstract][Full Text] [Related]
6. A Canadian evidence-based guideline for the first-line treatment of follicular lymphoma: joint consensus of the Lymphoma Canada Scientific Advisory Board.
Kuruvilla J; Assouline S; Hodgson D; MacDonald D; Stewart D; Christofides A; Komolova M; Connors J
Clin Lymphoma Myeloma Leuk; 2015 Feb; 15(2):59-74. PubMed ID: 25195028
[TBL] [Abstract][Full Text] [Related]
7. Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial.
Fowler NH; Davis RE; Rawal S; Nastoupil L; Hagemeister FB; McLaughlin P; Kwak LW; Romaguera JE; Fanale MA; Fayad LE; Westin JR; Shah J; Orlowski RZ; Wang M; Turturro F; Oki Y; Claret LC; Feng L; Baladandayuthapani V; Muzzafar T; Tsai KY; Samaniego F; Neelapu SS
Lancet Oncol; 2014 Nov; 15(12):1311-8. PubMed ID: 25439689
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma.
Witzig TE; Nowakowski GS; Habermann TM; Goy A; Hernandez-Ilizaliturri FJ; Chiappella A; Vitolo U; Fowler N; Czuczman MS
Ann Oncol; 2015 Aug; 26(8):1667-77. PubMed ID: 25712458
[TBL] [Abstract][Full Text] [Related]
9. Radiotherapy of follicular lymphoma: updated role and new rules.
Yahalom J
Curr Treat Options Oncol; 2014 Jun; 15(2):262-8. PubMed ID: 24700284
[TBL] [Abstract][Full Text] [Related]
10. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
[TBL] [Abstract][Full Text] [Related]
11. Transformed follicular non-Hodgkin lymphoma.
Casulo C; Burack WR; Friedberg JW
Blood; 2015 Jan; 125(1):40-7. PubMed ID: 25499449
[TBL] [Abstract][Full Text] [Related]
12. Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402.
Kahl BS; Hong F; Williams ME; Gascoyne RD; Wagner LI; Krauss JC; Habermann TM; Swinnen LJ; Schuster SJ; Peterson CG; Sborov MD; Martin SE; Weiss M; Ehmann WC; Horning SJ
J Clin Oncol; 2014 Oct; 32(28):3096-102. PubMed ID: 25154829
[TBL] [Abstract][Full Text] [Related]
13. Current therapeutic strategies and new treatment paradigms for follicular lymphoma.
Kritharis A; Sharma J; Evens AM
Cancer Treat Res; 2015; 165():197-226. PubMed ID: 25655611
[TBL] [Abstract][Full Text] [Related]
14. Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma.
Kiyasu J; Miyoshi H; Hirata A; Arakawa F; Ichikawa A; Niino D; Sugita Y; Yufu Y; Choi I; Abe Y; Uike N; Nagafuji K; Okamura T; Akashi K; Takayanagi R; Shiratsuchi M; Ohshima K
Blood; 2015 Nov; 126(19):2193-201. PubMed ID: 26239088
[TBL] [Abstract][Full Text] [Related]
15. Is observation dead in follicular lymphoma? No, but the apoptosis pathway has been activated.
Fisher RI; Khan N
J Natl Compr Canc Netw; 2015 Mar; 13(3):363-6. PubMed ID: 25736011
[TBL] [Abstract][Full Text] [Related]
16. Pathology of follicular lymphoma.
Takata K; Miyata-Takata T; Sato Y; Yoshino T
J Clin Exp Hematop; 2014; 54(1):3-9. PubMed ID: 24942941
[TBL] [Abstract][Full Text] [Related]
17. FDG PET-CT in follicular lymphoma: a case-based evidence review.
Smith SD; Redman M; Dunleavy K
Blood; 2015 Feb; 125(7):1078-82. PubMed ID: 25527711
[No Abstract] [Full Text] [Related]
18. Radiotherapy for stage I/II follicular lymphoma (FL): is it time for a re-appraisal?
Mondello P; Steiner N; Wasle I; Pitini V; Mian M
Anticancer Res; 2014 Nov; 34(11):6701-4. PubMed ID: 25368277
[TBL] [Abstract][Full Text] [Related]
19. Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.
Hoelzer D; Walewski J; Döhner H; Viardot A; Hiddemann W; Spiekermann K; Serve H; Dührsen U; Hüttmann A; Thiel E; Dengler J; Kneba M; Schaich M; Schmidt-Wolf IG; Beck J; Hertenstein B; Reichle A; Domanska-Czyz K; Fietkau R; Horst HA; Rieder H; Schwartz S; Burmeister T; Gökbuget N;
Blood; 2014 Dec; 124(26):3870-9. PubMed ID: 25359988
[TBL] [Abstract][Full Text] [Related]
20. Obinutuzumab for chronic lymphocytic leukemia.
Rioufol C; Salles G
Expert Rev Hematol; 2014 Oct; 7(5):533-43. PubMed ID: 25163491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]